Cancer Chemotherapy and Pharmacology

, Volume 59, Issue 1, pp 149–150

Negative results of an Italian Group for Mesothelioma (G.I.Me.) pilot study of single-agent imatinib mesylate in malignant pleural mesothelioma

Authors

    • Medical OncologyI.R.C.C.S. San Matteo University Hospital
  • Luciano Mutti
    • Local Health Authority 11
  • Gianfranco Tassi
    • PneumologyCivic Hospital
Letter to the Editor

DOI: 10.1007/s00280-006-0243-4

Cite this article as:
Porta, C., Mutti, L. & Tassi, G. Cancer Chemother Pharmacol (2007) 59: 149. doi:10.1007/s00280-006-0243-4

Copyright information

© Springer-Verlag 2006